Literature DB >> 8003553

Validation of a liquid chromatography post-column derivatization assay for the determination of cisplatin in plasma.

H H Farrish1, P H Hsyu, J F Pritchard, K R Brouwer, J Jarrett.   

Abstract

Method validation results are described for a cisplatin LC post-column derivatization assay. Cisplatin plasma samples were treated with acetonitrile and a citrate buffer solution to enhance cisplatin stability. Processed samples were analysed on a chemically generated anion exchange column using a customized post-column derivatization platform and refrigerated autosampler. The UV response was monitored at 290 nm. The retention time of cisplatin was 9 min. The assay was linear from 0.06 to 30.0 micrograms ml-1 (r > 0.998) with inter-run precisions (RSD) of 8.2% (n = 8), 5.9% (n = 8) and 4.0% (n = 8) for low (0.18 microgram ml-1), medium (1.5 microgram ml-1) and high (24.0 micrograms ml-1) quality control samples, respectively. The validated assay was used to monitor cisplatin levels in cisplatin drug interaction studies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8003553     DOI: 10.1016/0731-7085(94)90038-8

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  2 in total

1.  Cisplatin Concentrations in Long and Short Duration Infusion: Implications for the Optimal Time of Radiation Delivery.

Authors:  Pradeep Rajkumar; Binu Susan Mathew; Saikat Das; Rajesh Isaiah; Subashini John; Ratna Prabha; Denise Helen Fleming
Journal:  J Clin Diagn Res       Date:  2016-07-01

2.  Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometric (LC/ESI-MS/MS) Study for the Identification and Characterization of In Vivo Metabolites of Cisplatin in Rat Kidney Cancer Tissues: Online Hydrogen/Deuterium (H/D) Exchange Study.

Authors:  Raju Bandu; Hyun Soo Ahn; Joon Won Lee; Yong Woo Kim; Seon Hee Choi; Hak Jin Kim; Kwang Pyo Kim
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.